OptimizeRx Corp Insider Trading Activity
Every SEC Form 4 insider transaction reported for OptimizeRx Corp (OPRX), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are OPRX insiders buying or selling?
OptimizeRx Corp insiders reported 25 open-market buys ($4.1M) and 59 sells ($37.8M) across 84 Form 4 filings — a net selling position of $33.8M.
Source: SEC EDGAR Form 4
Key Statistics (as of Dec 22, 2025)
Insider sentiment
Net sellingNet insider flow of $33.8M in net selling.
Recent OPRX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 22, 2025 | Edward Stelmakh | Chief Finance & Strat Officer | Sale | 1.4K | $13.51 | $18.8K |
| Oct 7, 2025 | Stephen L Silvestro | Chief Executive Officer | Sale | 1.6K | $18.75 | $30.4K |
| Sep 11, 2025 | Patrick D Spangler | Director | Sale | 11.1K | $17.49 | $194.5K |
| Mar 19, 2025 | James Paul Lang | Director | Purchase | 321.4K | $7.60 | $2.4M |
| Dec 16, 2024 | William J Febbo | CEO | Purchase | 20.0K | $5.01 | $100.2K |
| Jan 11, 2024 | Marion Odence-Ford | General Counsel and CCO | Sale | 4.0K | $15.19 | $60.8K |
| Aug 23, 2022 | James Paul Lang | Director | Purchase | 6.0K | $16.45 | $98.7K |
| Aug 23, 2022 | William J Febbo | CEO | Purchase | 16.1K | $15.59 | $251.0K |
| Aug 17, 2022 | Stephen L Silvestro | CCO | Purchase | 3.2K | $15.66 | $50.1K |
| Aug 17, 2022 | Ellen O'Connor Vos | Director | Purchase | 500 | $15.91 | $8.0K |
| Aug 17, 2022 | Edward Stelmakh | CFO/COO | Purchase | 3.0K | $15.43 | $46.3K |
| Feb 23, 2022 | William J Febbo | CHIEF EXECUTIVE OFFICER | Sale | 16.7K | $43.73 | $728.8K |
| Jan 20, 2022 | William J Febbo | CHIEF EXECUTIVE OFFICER | Sale | 16.7K | $47.27 | $787.8K |
| Dec 21, 2021 | Stephen L Silvestro | CHIEF COMMERCIAL OFFICER | Sale | 13.2K | $54.87 | $726.5K |
| Dec 17, 2021 | William J Febbo | CHIEF EXECUTIVE OFFICER | Sale | 16.7K | $54.55 | $909.1K |
| Dec 3, 2021 | Miriam J Paramore | PRESIDENT AND CSO | Sale | 3.6K | $61.48 | $218.7K |
| Nov 19, 2021 | Stephen L Silvestro | CHIEF COMMERCIAL OFFICER | Sale | 13.2K | $73.98 | $979.6K |
| Nov 17, 2021 | William J Febbo | CHIEF EXECUTIVE OFFICER | Sale | 16.7K | $82.18 | $1.4M |
| Nov 15, 2021 | Patrick D Spangler | Director | Sale | 6.3K | $84.38 | $527.5K |
| Nov 3, 2021 | Miriam J Paramore | PRES. & CHIEF STRATEGY OFFICER | Sale | 15.0K | $95.45 | $1.4M |
| Oct 19, 2021 | Stephen L Silvestro | CHIEF COMMERCIAL OFFICER | Sale | 13.2K | $85.38 | $1.1M |
| Oct 19, 2021 | William J Febbo | CHIEF EXECUTIVE OFFICER | Sale | 16.7K | $84.20 | $1.4M |
| Oct 5, 2021 | Miriam J Paramore | PRESIDENT AND CSO | Sale | 15.0K | $84.67 | $1.3M |
| Oct 5, 2021 | Douglas P Baker | CHIEF FINANCIAL OFFICER | Sale | 14.0K | $82.88 | $1.2M |
| Sep 29, 2021 | Douglas P Baker | CHIEF FINANCIAL OFFICER | Sale | 2.0K | $74.66 | $149.3K |
Showing the 25 most recent of 84 Form 4 filings for OptimizeRx Corp.
Most active OPRX insiders
- Douglas P Baker26 filings
- William J Febbo14 filings
- Miriam J Paramore11 filings
- Stephen L Silvestro10 filings
- Ellen O'Connor Vos6 filings
Ask anything about OPRX insider activity
Use Trabud's AI agent to query OptimizeRx Corp's Form 4 history in plain English — "Show me OPRX CEO purchases this year" or compare it against any other ticker.
Open the AI agentOPRX insider trading FAQ
Are OptimizeRx Corp insiders buying or selling?
Across 84 SEC Form 4 filings, OptimizeRx Corp (OPRX) insiders reported 25 open-market purchases totaling $4.1M and 59 sales totaling $37.8M. That is a net selling position of $33.8M.
How many insiders trade OPRX stock?
13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for OptimizeRx Corp. The most recent filing was accepted on Dec 22, 2025.
Where does Trabud get OPRX insider trading data?
All OPRX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.